翰宇药业：董事兼执行总裁PINXIANG YU退休离任

Group 1 - The core point of the news is the retirement of Ms. Pinxiang Yu, the director and CEO of Hanyu Pharmaceutical, effective November 14, 2025, due to reaching retirement age [1] - After her retirement, Ms. Pinxiang Yu will no longer hold any positions within the company or its subsidiaries [1] - For the first half of 2025, Hanyu Pharmaceutical's revenue is entirely derived from the pharmaceutical manufacturing sector, accounting for 100% of its business [1] Group 2 - As of the report, Hanyu Pharmaceutical has a market capitalization of 17.1 billion yuan [2]